Project Funded

June/2015 – Project Funded. We are delighted to secure operating funding from the Women & Children Health Research Institute (WCHRI; $25,000/year x 2 years) to pursue a novel therapy for high risk B-cell acute lymphocytic leukaemia (ALL). Dr. Joseph Brandwein (Section Head, Hematology, U. of Alberta Hospital) is the Principal Investigator for this project and we will lend our expertise on siRNA delivery technology to this project. We highly value this seed investment from a local agency and we will use the funds to explore a unique molecular therapy for this most common childhood leukaemia.